Work

In Brief: A New Donanemab (Kisunla) Dosing Regimen for Alzheimer's Disease

Year: 2025

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2025.1735d

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413107914

FWCI:

Cites:

Cited by:

Related to: 10